LISDEXAMFETAMINE DIMESYLATE
These highlights do not include all the information needed to use LISDEXAMFETAMINE DIMESYLATE CAPSULES safely and effectively. See full prescribing information for LISDEXAMFETAMINE DIMESYLATE CAPSULES. LISDEXAMFETAMINE DIMESYLATE capsules, for oral use, CII Initial U.S. Approval: 2007
d918b40d-a461-41bc-b6c0-83dc76c28e32
HUMAN PRESCRIPTION DRUG LABEL
Jan 29, 2024
Rhodes Pharmaceuticals
DUNS: 831928986
Products 7
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
LISDEXAMFETAMINE DIMESYLATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
LISDEXAMFETAMINE DIMESYLATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (13)
LISDEXAMFETAMINE DIMESYLATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
LISDEXAMFETAMINE DIMESYLATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
LISDEXAMFETAMINE DIMESYLATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (13)
LISDEXAMFETAMINE DIMESYLATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
LISDEXAMFETAMINE DIMESYLATE
Product Details
FDA regulatory identification and product classification information